BLOG
Credibility, differentiation, awareness: the three pillars of effective life science comms and marketing
Our Head of Creative Lauren Gray digs into the three pillars that underpin life science comms and marketing: credibility, differentiation and awareness.
When It Comes to Biotech Fundraising, the Data Doesn’t Speak for Itself
Our founder and Chief Creative Officer Kat Arney explores what biotech companies need to be thinking about to secure investment in todays tough climate.
“We call you First Create The Magic!”
How we brought creativity and consistency to nonclinical development consultancy Leads To Development’s marketing communications.
From features to feelings: how to create life science messaging that lands
We show how life science product and service companies can move their messaging from just explaining what they do to articulating why it matters.
Coming out of stealth mode with a splash
How we raised awareness of innovative techbio startup Etcembly at a crucial time in their growth journey.
Comms advice for biotech startups after raising Series A: From startup to scaleup
How biotech companies can build consistent, credible communications as they transition from startup to scaleup following a Series A raise.
Comms advice for biotech startups raising Series A: Building momentum and investor confidence
Practical guidance for biotech founders raising Series A on building visibility, coherence and investor confidence without last-minute panic.
Comms advice for Seed-stage biotech startups: From stealth to substance
How Seed-stage biotech startups should approach communications, LinkedIn and PR to build credibility, attract talent and lay the groundwork for the next raise.
Comms advice for pre-seed biotech startup founders: Getting your story straight from the start
Advice for biotech startup founders at pre-seed stage on how to communicate their science clearly and credibly when preparing to raise a Seed round.
Building a biotech startup? Don’t forget to evolve your story alongside your science
Whether you’re getting ready to raise or have just closed a funding round, Kat Arney shares how your biotech startup story and comms need to evolve.